Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy. [electronic resource]
Producer: 20200603Description: 293-300 p. digitalISSN:- 1549-490X
- Adenocarcinoma -- drug therapy
- Aged, 80 and over
- Antineoplastic Agents, Immunological -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Carmustine -- pharmacology
- Cetuximab -- pharmacology
- Cytarabine -- pharmacology
- ErbB Receptors -- pharmacology
- Etoposide -- pharmacology
- Genotype
- Humans
- Intestinal Neoplasms -- drug therapy
- Liquid Biopsy -- methods
- Male
- Melphalan -- pharmacology
- Paranasal Sinus Neoplasms -- drug therapy
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.